so it's not just cml.es of potentially well over $2.5 billion in peak sales really is entirely based upon cml. doesn't take into account any of the other indications which obviously are part of what we're exploring now. >> all right. explain how it works. you take a pill each day? >> you take one pill each day. patients probably will receive the drug for many, many years, but a pill a day, relatively easy, well tolerated based on the data we have so far, and very easy for patients to live with the drug and thus live with their disease over many, many years long term. >> okay. now, you unlike a lot of other companies i deal with are choosing what seems to be go it alone on this. you've got a new discovery, got a development, got to commercialize it. why go it alone? it costs a fortune to get something ultimately through the fda. >> well, yes, it costs a lot of money but really, to create value for our shareholders and create a sustainable business, the model we have will work. discovery of drugs, develop th